UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil®) versus conventional doxorubicin for first-line treatment of metastatic breast cancer

Annals of oncology, 2004-03, Vol.15 (3), p.440-449

2004

Volltextzugriff (PDF)

Central nervous system progression among patients with metastatic breast cancer responding to trastuzumab treatment

European journal of cancer (1990), 2004-02, Vol.40 (3), p.379-382

2004

Volltextzugriff (PDF)

Doxorubicin and Paclitaxel Versus Fluorouracil, Doxorubicin, and Cyclophosphamide as First-Line Therapy for Women With Metastatic Breast Cancer: Final Results of a Randomized Phase III Multicenter Trial

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1707-1715

2001

Volltextzugriff (PDF)

Detailed analysis of a randomized phase III trial: can the tolerability of capecitabine plus docetaxel be improved without compromising its survival advantage?

Annals of oncology, 2006-09, Vol.17 (9), p.1379-1385

2006

Volltextzugriff (PDF)

The CC chemokine RANTES in breast carcinoma progression: Regulation of expression and potential mechanisms of promalignant activity

Cancer research (Chicago, Ill.), 2002-02, Vol.62 (4), p.1093-1102

2002

Volltextzugriff (PDF)

Correlation between c-erbB-4 receptor expression and response to gemcitabine—cisplatin chemotherapy in non-small-cell lung cancer

Annals of oncology, 2001-08, Vol.12 (8), p.1127-1131

2001

Volltextzugriff (PDF)

Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer

Annals of oncology, 2004-03, Vol.15 (3), p.440-449

2004

Volltextzugriff (PDF)

Encephalopathy in ifosfamide-treated patients

Acta neurologica Scandinavica, 1992-11, Vol.86 (5), p.521-525

1992

Volltextzugriff (PDF)

Small cell carcinoma of the gallbladder: clinical course and response to chemotherapy

Tumori, 1992-06, Vol.78 (3), p.207-210

1992

Volltextzugriff (PDF)

Cisplatin-related Lhermitteʼs sign

Anti-cancer drugs, 1992-08, Vol.3 (4), p.375-378

1992

Volltextzugriff (PDF)

COMBINED POSTOPERATIVE RADIOTHERAPY AND PCV-CHEMOTHERAPY (CCNU, PROCARBAZINE AND VINCRISTINE) IN MANAGING ANAPLASTIC ASTROCYTOMA - A REPORT OF A LONG-TERM FOLLOW-UP

International journal of oncology, 1993-06

1993

Volltextzugriff (PDF)

Classical disseminated Kaposi's sarcoma in HIV-negative patients; an unusually indolent subtype

British journal of cancer, 1993-10, Vol.68 (4), p.775-776

1993

Volltextzugriff (PDF)

Primary spinal epidural non-Hodgkin's lymphoma. The contribution of nuclear magnetic resonance imaging, therapeutic approach and review of the literature

Tumori, 1992-12, Vol.78 (6), p.397-402

1992

Volltextzugriff (PDF)

Breast carcinoma: a report on the potential usage of the CC chemokine RANTES as a marker for a progressive disease

The Israel Medical Association journal, 2002-11, Vol.4 (11 Suppl), p.940-943

2002

Volltextzugriff (PDF)

Radiation therapy of metastatic spinal cord compression : Multidisciplinary team diagnosis and treatment

Journal of neuro-oncology, 1999-03, Vol.42 (1), p.85-92

1999

Volltextzugriff (PDF)

Correlation between C-ERBB-4 receptor expression and response to gemcitabine-cisplatin chemotherapy in non-small cell lung cancer

European journal of cancer (1990), 2001-04, Vol.37, p.S55-S55

2001

Volltextzugriff (PDF)

Gemcitabine—cisplatin combination in metastatic non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2000-09, Vol.29 (1), p.59-59

2000

Volltextzugriff (PDF)

Treatment of disease-negative but mucin-like carcinoma-associated antigen-positive breast cancer patients with tamoxifen : preliminary results of a prospective controlled randomized trial

Cancer chemotherapy and pharmacology, 1994-01, Vol.35 (1), p.80-83

1994

Volltextzugriff (PDF)

CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus CNF (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer results by demographic and clinical subgroups

American journal of clinical oncology, 2002-10, Vol.25 (5), p.520-522

2002

Volltextzugriff (PDF)

Monthly gemcitabine (days 1, 8 and 15) plus cisplatin (days 1-3) in advanced non-small cell lung cancer: a phase II study

Anti-cancer drugs, 2000-02, Vol.11 (2), p.117-121

2000

Volltextzugriff (PDF)

CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus CNF (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer a phase III randomized multicenter study

American journal of clinical oncology, 2001-08, Vol.24 (4), p.323-327

2001

Volltextzugriff (PDF)

Randomized open-label phase III multicenter trial comparing TAXOL®/doxorubicin (AT) versus 5-fluorouracil/doxorubicin and cyclophosphamide (FAC) as a first line treatment for patients with metastatic breast cancer

European journal of cancer (1990), 1999-09, Vol.35, p.S314-S314

1999

Volltextzugriff (PDF)

The role of routine pelvic lymph node sampling in patients with stage I endometrial carcinoma, second thoughts

Acta obstetricia et gynecologica Scandinavica, 1998-03, Vol.77 (3), p.347-350

1998

Volltextzugriff (PDF)

Combined postoperative radiotherapy and PVC-chemotherapy (procarbazine, CCNU and vincristine) in managing anaplastic astrocytoma — A long-term follow-up

European journal of cancer (1990), 1993, Vol.29, p.S193-S193

1993

Volltextzugriff (PDF)

A Phase II Trial of D-Trp-6-LHRH (Decapeptyl) in Pretreated Patients with Advanced Epithelial Ovarian Cancer

Cancer investigation, 1995, Vol.13 (3), p.272-275

1995

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(65)

Publikationsform

Sprache

Englisch
(77)
Hebräisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Humans
(45)
Life Sciences & Biomedicine
(38)
Female
(29)
Biological And Medical Sciences
(28)
Middle Aged
(22)
Oncology
(19)
Adult
(18)
Male
(18)
Medical Sciences
(18)
Molecular Sequence Data
(15)
Aged
(12)
Base Sequence
(12)
Multidisciplinary Sciences
(12)
Science & Technology - Other Topics
(12)
Animals
(11)
Fundamental And Applied Biological Sciences. Psychology
(10)
Breast Neoplasms - Pathology
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Pharmacology. Drug Treatments
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil®) versus conventional doxorubicin for first-line treatment of metastatic breast cancer

Central nervous system progression among patients with metastatic breast cancer responding to trastuzumab treatment

Doxorubicin and Paclitaxel Versus Fluorouracil, Doxorubicin, and Cyclophosphamide as First-Line Therapy for Women With Metastatic Breast Cancer: Final Results of a Randomized Phase III Multicenter Trial

Detailed analysis of a randomized phase III trial: can the tolerability of capecitabine plus docetaxel be improved without compromising its survival advantage?

The CC chemokine RANTES in breast carcinoma progression: Regulation of expression and potential mechanisms of promalignant activity

Correlation between c-erbB-4 receptor expression and response to gemcitabine—cisplatin chemotherapy in non-small-cell lung cancer

Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer

Encephalopathy in ifosfamide-treated patients

Small cell carcinoma of the gallbladder: clinical course and response to chemotherapy

Cisplatin-related Lhermitteʼs sign

COMBINED POSTOPERATIVE RADIOTHERAPY AND PCV-CHEMOTHERAPY (CCNU, PROCARBAZINE AND VINCRISTINE) IN MANAGING ANAPLASTIC ASTROCYTOMA - A REPORT OF A LONG-TERM FOLLOW-UP

Classical disseminated Kaposi's sarcoma in HIV-negative patients; an unusually indolent subtype

Primary spinal epidural non-Hodgkin's lymphoma. The contribution of nuclear magnetic resonance imaging, therapeutic approach and review of the literature

Breast carcinoma: a report on the potential usage of the CC chemokine RANTES as a marker for a progressive disease

Radiation therapy of metastatic spinal cord compression : Multidisciplinary team diagnosis and treatment

Correlation between C-ERBB-4 receptor expression and response to gemcitabine-cisplatin chemotherapy in non-small cell lung cancer

Gemcitabine—cisplatin combination in metastatic non-small cell lung cancer

Treatment of disease-negative but mucin-like carcinoma-associated antigen-positive breast cancer patients with tamoxifen : preliminary results of a prospective controlled randomized trial

CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus CNF (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer results by demographic and clinical subgroups

Monthly gemcitabine (days 1, 8 and 15) plus cisplatin (days 1-3) in advanced non-small cell lung cancer: a phase II study

CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus CNF (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer a phase III randomized multicenter study

Randomized open-label phase III multicenter trial comparing TAXOL®/doxorubicin (AT) versus 5-fluorouracil/doxorubicin and cyclophosphamide (FAC) as a first line treatment for patients with metastatic breast cancer

The role of routine pelvic lymph node sampling in patients with stage I endometrial carcinoma, second thoughts

Combined postoperative radiotherapy and PVC-chemotherapy (procarbazine, CCNU and vincristine) in managing anaplastic astrocytoma — A long-term follow-up

A Phase II Trial of D-Trp-6-LHRH (Decapeptyl) in Pretreated Patients with Advanced Epithelial Ovarian Cancer

Suchergebnisse filtern